-quidar
Drugs meant to overcome multidrug resistance in cancer cells.
- Drugs ending in -quidar: 5
- Approved somewhere: 0
- With a US drug page: 0
- Stem
- -quidar
- Class
- Drugs meant to overcome multidrug resistance in cancer cells
- Most common targets
- ABCB1 (3)
Approved and clinical-stage drugs in ChEMBL whose names ending in -quidar, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Encequidar | Phase 3 | ABCB1 | P-glycoprotein 1 inhibitor |
| Tariquidar | Phase 3 | ABCB1 | P-glycoprotein 1 inhibitor |
| Zosuquidar | Phase 3 | ABCB1 | P-glycoprotein 1 inhibitor |
| Laniquidar | Phase 2 | — | — |
| Dofequidar | Phase 1 | — | — |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO